Hicklin, Daniel J.'s most recent trade in Werewolf Therapeutics Inc was a trade of 592,690 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Daniel J. Hicklin, | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 592,690 | 592,690 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Daniel J. Hicklin, | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 185,652 | 185,652 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Hicklin, Daniel J. | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 435,000 | 435,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Daniel J. Hicklin, | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 295,500 | 295,500 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Daniel J. Hicklin, | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 215,888 | 215,888 | - | - | Stock Option (right to buy) |